The unusual features of cHL are its distinctive histological appearance, age bimodality, association with EBV, B symptoms, amplification of the gene that ensures PD-L1 expression, and unpredictable therapeutic response. This evidence concerns the gene CD274 and classic Hodgkin lymphoma.